Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-12

FDA Approved: GABAPENTIN — Original Application (Laurus Labs Limited)

View source ↗

Summary

FDA approved Laurus Labs' generic Gabapentin original application. The approval covers its use for partial seizures and postherpetic neuralgia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

ORIG AP for GABAPENTIN (GABAPENTIN)